Quantcast

Latest BioLineRx Stories

2014-07-01 16:30:03

HAMPTON, N.J., July 1, 2014 /PRNewswire/ -- Bellerophon Therapeutics, LLC, a clinical stage biotherapeutics company, leveraging its proprietary drug-device technology platform for the development

2014-03-03 16:26:07

JERUSALEM, March 3, 2014 /PRNewswire/ -- BioLineRx (NASDAQ: BLRX; TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic

2014-02-12 08:28:26

- BL-8040 study published in Molecular Cancer Therapeutics - JERUSALEM, Feb.

2014-01-23 08:30:32

- BL-8040 previously received Orphan Drug Designation for treatment of Acute Myeloid Leukemia - JERUSALEM, Jan.

2014-01-13 08:26:47

Phase 1 Trial of BL-8040 expected to begin in Q2 2014; top-line results expected in H2 2014 JERUSALEM, Jan.

2014-01-08 08:27:23

- JHL Biotech to develop and commercialize BL-9020 in China and additional Southeast Asia countries - JERUSALEM and HSINCHU, Taiwan, Jan.


Word of the Day
abactinal
  • Pertaining to the surface or end opposite to the mouth in a radiate animal.
The word 'abactinal' comes from a Greek root meaning 'ray' and a Latin prefix meaning 'away'.
Related